Kuwaiti researchers secure U.S. patent for innovative sleep apnea test
In a landmark achievement for national research and innovation, a team from the Dasman Diabetes Institute — established by the Kuwait Foundation for the Advancement of Sciences (KFAS) in collaboration with the Ministry of Health — has been granted a patent by the United States Patent and Trademark Office (USPTO) for a groundbreaking diagnostic test for sleep apnea.
The patented test, a qualitative blood-based method, enables early detection of sleep apnea, a widespread condition linked to serious complications such as type 2 diabetes, hypertension, and cardiovascular diseases including angina and heart attacks. This milestone marks the first of three patents currently under development by the institute.
The invention is the product of extensive collaboration led by Dr. Abdul Mohsen Ibrahim Al-Turki, Consultant Otorhinolaryngologist and Head and Neck Surgeon at the Ministry of Health, who worked closely with the Dasman Diabetes Institute’s research team under the supervision of Professor Fahad Al-Mulla, Chief Scientific Officer. Their efforts were further supported by Dr. Faisal Hamed Al-Refaei, Acting Director General of the Institute.
This success highlights the strength of institutional cooperation, particularly between the Dasman Diabetes Institute and the Sabah Al-Ahmad Center for Giftedness and Creativity, both operating under the umbrella of KFAS.
Together, they are advancing an integrated strategy to support Kuwaiti researchers, empower young talent, and launch pioneering programs that raise the quality of scientific research. These efforts not only enhance public health but also reinforce Kuwait’s position in regional and global scientific communities.
Follow The Times Kuwait on X, Instagram and Facebook for the latest news updates
